1. Home
  2. TOPP vs MIRA Comparison

TOPP vs MIRA Comparison

Compare TOPP & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOPP
  • MIRA
  • Stock Information
  • Founded
  • TOPP 2014
  • MIRA 2020
  • Country
  • TOPP United States
  • MIRA United States
  • Employees
  • TOPP N/A
  • MIRA N/A
  • Industry
  • TOPP
  • MIRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • TOPP
  • MIRA Health Care
  • Exchange
  • TOPP NYSE
  • MIRA Nasdaq
  • Market Cap
  • TOPP 22.4M
  • MIRA 20.5M
  • IPO Year
  • TOPP 2025
  • MIRA 2023
  • Fundamental
  • Price
  • TOPP $1.22
  • MIRA $0.94
  • Analyst Decision
  • TOPP
  • MIRA Strong Buy
  • Analyst Count
  • TOPP 0
  • MIRA 2
  • Target Price
  • TOPP N/A
  • MIRA $14.00
  • AVG Volume (30 Days)
  • TOPP 91.6K
  • MIRA 2.7M
  • Earning Date
  • TOPP 01-01-0001
  • MIRA 05-12-2025
  • Dividend Yield
  • TOPP N/A
  • MIRA N/A
  • EPS Growth
  • TOPP N/A
  • MIRA N/A
  • EPS
  • TOPP 0.01
  • MIRA N/A
  • Revenue
  • TOPP $16,039,513.00
  • MIRA N/A
  • Revenue This Year
  • TOPP N/A
  • MIRA N/A
  • Revenue Next Year
  • TOPP N/A
  • MIRA N/A
  • P/E Ratio
  • TOPP $104.65
  • MIRA N/A
  • Revenue Growth
  • TOPP N/A
  • MIRA N/A
  • 52 Week Low
  • TOPP $1.05
  • MIRA $0.51
  • 52 Week High
  • TOPP $4.50
  • MIRA $5.01
  • Technical
  • Relative Strength Index (RSI)
  • TOPP N/A
  • MIRA 46.83
  • Support Level
  • TOPP N/A
  • MIRA $0.78
  • Resistance Level
  • TOPP N/A
  • MIRA $1.33
  • Average True Range (ATR)
  • TOPP 0.00
  • MIRA 0.09
  • MACD
  • TOPP 0.00
  • MIRA 0.01
  • Stochastic Oscillator
  • TOPP 0.00
  • MIRA 34.83

About TOPP TOPPOINT HOLDINGS INC

Toppoint Holdings Inc is a truckload services and solutions provider focused on the recycling export supply chain.

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Share on Social Networks: